Drug-resistant tuberculosis: An insurmountable epidemic?

Inflammopharmacology

Volumn 19, Issue 3, 2011, Pages 131-137

  Chakroborty, Amitabha ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Directly observed treatment (DOT); Extensively drug resistant tuberculosis (XDR TB); Multi drug resistant tuberculosis (MDR TB); Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

AIDS RELATED COMPLEX; DIRECTLY OBSERVED THERAPY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; PRACTICE GUIDELINE; REVIEW; WORLD HEALTH ORGANIZATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES AS TOPIC; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84855559732     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-010-0072-2     Document Type: Review

References (25)

1. Abdool Karim SS, Naidoo K, Grober A, Padayatchi N et al (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. NEJM 362:697-706
2. Acuna-Villaordune C, Vassal A, Henostroza G et al (2008) Cost-effectiveness analysis of introduction of rapid alternative methods to identify multi drug resistant tuberculosis in middleincome countries. Clin Infect Dis 47:487-495
3. Boehme CC, Nabeta P, Hillermann D et al (2010) Rapid molecular detection of Tuberculosis and Rifampin resistance. NEJM 363:1005-1015
4. Diacon AH, Alexander P, Martin G et al (2010) The diarylquinoline TMC 207 for multidrug resistant tuberculosis. N Engl J Med 360(23):2397-2405
5. Espinal MA, Laszlo A, Simonsen L et al (2001) Global trends in the resistance to antituberculosis drugs. NEJM 344:1294-1303 (Pubitemid 32377203)
6. Gandhi NR, Moll A, Sturm AW et al (2006) Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 365:1575-1580 (Pubitemid 44780738)
7. Gupta R, Cegielski JP, Espinal MA, Henkens M et al (2002) Increasing transparency in partnership for health introducing the Green Light Committee. Trop Med Int Health 7:970-976 (Pubitemid 35356618)
8. Keshavjee S, Gelmanova IY, Farmer PE et al (2008) Treatment of extensively drug resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 372:1403-1409
9. Keshavjee S, Farmer PE et al (2010) Picking up the pace: scale-up of MDR Tuberculosis Treatment Programs. NEJM 363:1781-1784
10. Kim H-R, Hwang SS, Kim HJ et al (2007) Impact of extensive drug resistance on treatment outcomes in non-HIV infected patients with multidrug resistant tuberculosis. Clin Infect Dis 45:1290-1295 (Pubitemid 351418994)
11. Mak A, Thomas A, del Granado M, Zaleskis R et al (2008) Influence of multidrug resistance on tuberculosis treatment outcome with standardized regimens. Am J Respir Crit Care Med 178:306-312
12. Migliori GB, Ortmann J, Girardi E et al (2007) Extensively drug resistant tuberculosis, in Italy and Germany. Emerg Infect Dis 13:780-781
13. Mitnick CD, Shin SS, Seung KJ et al (2008) Comprehensive treatment of extensively drug resistant tuberculosis. NEJM 359:563-574
14. Mohan AK, Cote TR, Block JA et al (2004) Tuberculosis following the use of etanercept, a tumour necrosis factor inhibitor. Clin Infect Dis 39:296-299
15. MMWR (2006) Morb Mortal Wkly Rep 55:301
16. Mukherjee JS, Michael LR, Adrienne RS et al (2004) Lancet 363:474-481
17. Piatck AS, Talenti A, Murray MR et al (2000) Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 44:103-110 (Pubitemid 30010679)
18. Sacks LV, Pendle S, Orlovic D, Blumberg L, Constantinou C (1999) A comparison of outbreak- and nonoutbreak-related MDR-TB among HIV infected patients in a South African hospital. Clin Infect Dis 29(1):96-101 (Pubitemid 29336809)
19. Scano F, Vitoria M, Burman W, Harries AD et al (2008) Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. Int J Tuberc Lung Dis 12(12):1370-1375
20. Shah NS, Robert B, Armstrong L et al (2008) Extensively drug resistant tuberculosis in USA, 1993-2007, JAMA 300(18):2153-2160
21. Telent A, Imbodem P, Marcheri F et al (1993) Detection of rifampicin resistance in Mycobacterium tuberculosis. Lancet 341:647-650
22. WHO (2006) Guideline for programmatic management of drug resistant tuberculosis. WHO, Geneva
23. WHO (2008) Guideline for programmatic management of drug resistant tuberculosis. WHO, Geneva
24. WHO Report (2006) Stop TB strategy
25. WHO Report (2009) Global Tuberculosis Control